This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
CHANGE IN RATINGSTD Ameritrade(AMTD - Get Report) downgraded at Citigroup to Neutral from Buy, Citigroup said. Retail trading re-engagement risks re-ignite.
Boeing(BA - Get Report) upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $80 price target. Aerospace cycle remains strong.
Buckeye Technologies(BKI) upgraded at UBS to Buy from Neutral, UBS said. $36 price target. Risks are higher, but sell off seems overdone.
Cummins(CMI) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Company is leveraged to a likely NAFTA truck inventory correction later this year.
Facebook(FB - Get Report) rated new Underperform at Bernstein. $25 price target. Company will likely struggle to achieve sales growth targets.
Huntington Bancshares(HBAN) downgraded at FBR from Market Perform to Underperform, FBR Capital Markets said. $6 price target. Company is leveraged to lower interest rates.
HealthSouth(HLS) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call.
KAR Auction(KAR) upgraded at Baird to Outperform, Robert Baird said. Valuation call, based on a $21 price target.
NY Community Bancorp(NYB) downgraded at FBR. NYB was downgraded from Outperform to Market Perform, FBR Capital Markets said. $13.50 price target. Estimates also cut, given lower expected net interest margin.
PG&E(PCG - Get Report) rated new Equal-weight at Morgan Stanley. $47 price target. Risk/reward is neutral at cuirrent levels.
Pioneer Natural(PXD) upgraded at Societe Generale from Sell to Hold, Societe Generale said. Valuation call, based on a $92 price target.
Regions Financial(RF) downgraded at Morgan Stanley from Buy to Hold, Morgan Stanley said. $6.50 price target. Company is leveraged to slower macro growth and lower interest rates.
Charles Schwab(SCHW) downgraded at Citigroup to Neutral from Buy, Citigroup said. Retail trading re-engagement risks re-ignite.
Zions Bancorporation(ZION - Get Report) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $21 price target. Company needs to cut costs, to cope with the lower interest rate environment.
STOCK COMMENTS / EPS CHANGES
Express Scripts(ESRX) numbers lowered at BMO through 2013, BMO Capital said. Company is facing higher debt costs, following the Medco merger. Market Perform rating and new $50 price target.